GlassScriptPhysician profile
Mark Staroselsky
NPI 1659864197
$2,750.16
in general payments reported to CMS, 2019-2025
14 companies · $881 in 2025
The $881 reported for 2025 was more than what 83% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $266 · 2022: $27.45 · 2023: $459 · 2024: $1,117 · 2025: $881.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,457.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,457.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $784.88 | 2022-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip, Aveir |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $442.37 | 2023-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $300.16 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $239.66 | 2024-2025 | Jardiance |
| Medtronic, INC. | $237.57 | 2024-2025 | Corevalve Evolut R, Symplicity G3 |
| Boston Scientific Corporation | $227.28 | 2021-2024 | Ingevity+, Watchman Access System |
| Bridgebio Pharma, INC. | $128.27 | 2025 | Attruby |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2025 | Lokelma |
| Pfizer INC. | $86.13 | 2023-2025 | |
| Lantheus Medical Imaging, INC. | $61.67 | 2023-2024 | Definity |
| Amgen INC. | $54.42 | 2025 | Repatha |
| Terumo Medical Corporation | $23.29 | 2025 | Angio-Seal, Progreat, Metacross Otw |
| La Jolla Pharmaceutical Company | $20.02 | 2023 | Giapreza |
| Chiesi USA, INC. | $19.44 | 2023 | Cleviprex, Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Staroselsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.